Cargando…

Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors

Invariant natural killer T (iNKT) cells recognize self-lipids presented by CD1d through characteristic TCRs, which mainly consist of the invariant Vα14-Jα18 TCRα chain and Vβ8.2, 7 or 2 TCRβ chains with hypervariable CDR3β sequences in mice. The iNKT cell-CD1d axis is conserved between humans and mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Tingxi, Chamoto, Kenji, Nakatsugawa, Munehide, Ochi, Toshiki, Yamashita, Yuki, Anczurowski, Mark, Butler, Marcus O., Hirano, Naoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877060/ https://www.ncbi.nlm.nih.gov/pubmed/27213277 http://dx.doi.org/10.1371/journal.pone.0156114

Ejemplares similares

CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells
por: Nakatsugawa, Munehide, et al.
Publicado: (2016)

Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP(84Gly)
por: Anczurowski, Mark, et al.
Publicado: (2018)

HLA-DP(84Gly) constitutively presents endogenous peptides generated by the class I antigen processing pathway
por: Yamashita, Yuki, et al.
Publicado: (2017)

DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models
por: Kagoya, Yuki, et al.
Publicado: (2018)

Adoptive T Cell Therapy Targeting CD1 and MR1
por: Guo, Tingxi, et al.
Publicado: (2015)

A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects
por: Kagoya, Yuki, et al.
Publicado: (2018)

Invariant natural killer T cells recognize lipid self-antigen induced by microbial danger signals
por: Brennan, Patrick J., et al.
Publicado: (2011)

Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma
por: Murata, Kenji, et al.
Publicado: (2020)

Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire
por: Millar, Douglas G., et al.
Publicado: (2023)

Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d‐independent manner
por: Aoki, Takahiro, et al.
Publicado: (2020)

A clinical grade cell-based artificial APT, aAPC/mOKT3, for unbiased expansion of CD3+ T lymphocytes
por: Sotov, Valentin, et al.
Publicado: (2014)

Primary Lung Adenocarcinoma With ALK Gene Rearrangement Mostly Occupied by the Signet-Ring Cell Carcinoma Component: A Case Report
por: Okimura, Akira, et al.
Publicado: (2023)

α-galactosylceramide-stimulated invariant natural killer T-cells play a protective role in murine vulvovaginal candidiasis by Candida albicans
por: Abe, Masahiro, et al.
Publicado: (2021)

Lipid-Antigen Presentation by CD1d(+) B Cells Is Essential for the Maintenance of Invariant Natural Killer T Cells
por: Bosma, Anneleen, et al.
Publicado: (2012)

Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells
por: Engelen, Suzanne E., et al.
Publicado: (2023)

Invariant Natural Killer T and Mucosal-Associated Invariant T Cells in Asthmatic Patients
por: Lezmi, Guillaume, et al.
Publicado: (2018)

Myxofibrosarcoma of the Breast: A Case Report
por: Amaya, Keigo, et al.
Publicado: (2023)

Genetic control of murine invariant natural killer T-cells maps to multiple type 1 diabetes regions
por: Tsaih, Shirng-Wern, et al.
Publicado: (2013)

Antitumor Responses of Invariant Natural Killer T Cells
por: Altman, Jennie B., et al.
Publicado: (2015)

Immunometabolic Activation of Invariant Natural Killer T Cells
por: Ververs, Francesca A., et al.
Publicado: (2018)

Antigen specificity of invariant natural killer T-cells
por: Birkholz, Alysia M., et al.
Publicado: (2015)

The two faces of invariant natural killer T cells
por: Walton, Emma L.
Publicado: (2015)

Metabolism in Invariant Natural Killer T Cells: An Overview
por: Yarosz, Emily L., et al.
Publicado: (2021)

Invariant natural killer T cells in lung diseases
por: Jeong, Dongjin, et al.
Publicado: (2023)

Hiding Lipid Presentation: Viral Interference with CD1d-Restricted Invariant Natural Killer T (iNKT) Cell Activation
por: Horst, Daniëlle, et al.
Publicado: (2012)

Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy
por: Nobuoka, Daisuke, et al.
Publicado: (2012)

Characterization of CD8(+) T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutions
por: Shinkawa, Tomoyo, et al.
Publicado: (2021)

Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized
Publicado: (1987)

Atheroembolic kidney disease: The under‐recognized silent killer
por: Ștefan, Gabriel, et al.
Publicado: (2021)

Invariant NKT cells recognize glycolipids from pathogenic Gram-positive bacteria
por: Kinjo, Yuki, et al.
Publicado: (2011)

Invariant NKT cells: Killers and conspirators against cancer
por: Bassiri, Hamid, et al.
Publicado: (2013)

Lineage Differentiation Program of Invariant Natural Killer T Cells
por: Kwon, Dong-il, et al.
Publicado: (2017)

Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity
por: Van Kaer, Luc, et al.
Publicado: (2018)

Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells
por: Garner, Lucy C., et al.
Publicado: (2018)

Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control
por: Kinjo, Yuki, et al.
Publicado: (2018)

TLR4, 5, and 9 Agonists Inhibit Murine Airway Invariant Natural Killer T Cells in an IL-12-Dependent Manner
por: Shim, Jae-Uoong, et al.
Publicado: (2012)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells
por: Popovic, Zoran V., et al.
Publicado: (2017)

Harnessing invariant natural killer T cells to control pathological inflammation
por: Bharadwaj, Nikhila S., et al.
Publicado: (2022)

Murine Macrophage Requires CD11b to Recognize Talaromyces marneffei
por: Hu, Yongxuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gg7a8d5udg2dpdj2cd7mufi0uk